The Affiliated Hospital of Nanjing University Medical School, Nanjing Drum Tower Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
3 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chen, Bing
FUMANBA-1, NCT05066646: A Phase 1/2 Study of a Fully Human BCMA-targeting CAR (CT103A) in Patients With Relapsed/Refractory Multiple Myeloma

Recruiting
1/2
132
RoW
CT103A
Nanjing IASO Biotherapeutics Co.,Ltd
Multiple Myeloma
10/22
06/24
iinnovate-1, NCT03215030 / 2021-006038-37: A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma

Completed
1/2
272
Europe, Canada, Japan, US, RoW
Modakafusp alfa, TAK-573, TEV-48573, Dexamethasone
Takeda, Takeda Development Center Americas, Inc.
Multiple Myeloma
07/24
11/24
FUMANBA-2, NCT05181501: A Study of Fully Human BCMA CAR-T (CT103A) in Patients With Newly Diagnosed High-risk Multiple Myeloma

Not yet recruiting
1
20
RoW
Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A), CT103A
Nanjing IASO Biotherapeutics Co.,Ltd
Multiple Myeloma
04/24
04/39

Download Options